Related by context. All words. (Click for frequent words.) 74 tamoxifen 71 anastrozole 71 letrozole 71 hormonal therapy 69 virologic failure 69 Femara 69 exemestane 69 neoadjuvant chemotherapy 69 adjuvant therapy 68 bisphosphonate therapy 68 adjuvant hormonal therapy 68 docetaxel chemotherapy 67 chemoradiotherapy 67 warfarin therapy 67 aromatase inhibitor 67 antidepressant therapy 67 adjuvant tamoxifen 67 DAPT 67 preoperative chemotherapy 67 postoperative chemotherapy 67 hormone therapy 66 androgen deprivation 66 decitabine 66 lipid lowering therapy 66 EBRT 66 prior chemotherapy regimens 66 flutamide 66 chemoradiation 66 cilostazol 66 standard chemotherapy regimen 66 APTIVUS r 66 adalimumab 66 hormonal therapies 66 peginterferon 66 virological failure 66 FOLFOX4 65 GnRH agonists 65 trastuzumab 65 beta blocker therapy 65 mycophenolate mofetil 65 XELOX 65 neoadjuvant 65 neoadjuvant treatment 65 ARIMIDEX 65 Mylotarg 65 adjuvant radiotherapy 65 goserelin 65 letrozole Femara 65 eribulin 64 anthracycline taxane 64 adjuvant chemotherapy 64 abiraterone acetate 64 sunitinib 64 antiandrogen 64 chemotherapeutic regimens 64 pegylated liposomal doxorubicin 64 DMARD therapy 64 estrogen progestin therapy 64 androgen suppression 64 intravenous bisphosphonates 64 abatacept 64 estrogen therapy 64 CMV disease 64 androgen suppression therapy 64 Tamoxifen 64 cytotoxic therapy 64 endometrial carcinoma 64 Aromasin 64 abiraterone 64 interferon therapy 64 pCR 64 azacitidine 64 adjuvant radiation 64 HAART regimens 64 zoledronic acid 63 chlorambucil 63 lymph node dissection 63 cytoreduction 63 adjuvant tamoxifen therapy 63 methotrexate therapy 63 ZOLINZA 63 cART 63 antiplatelet therapy 63 GnRH agonist 63 cisplatin chemotherapy 63 cystectomy 63 Herceptin trastuzumab 63 menopausal hormone therapy 63 topotecan 63 recurrent VTE 63 iniparib 63 imatinib therapy 63 oophorectomy 63 biochemical relapse 63 tibolone 63 GVAX 63 lamivudine 63 lipid lowering drugs 63 androgen ablation 63 superficial bladder cancer 63 abnormal Pap test 63 neoadjuvant therapy 63 BYSTOLIC 63 alteplase 63 relapsed MM 63 taxane therapy 63 TORISEL 63 metformin 63 postmenopausal hormone therapy 63 carboplatin paclitaxel 63 anticoagulation therapy 62 cranial radiation 62 Jevtana 62 debulking surgery 62 HAART regimen 62 Doxil ® 62 Exemestane 62 curative resection 62 trastuzumab Herceptin 62 chemotherapy regimen 62 lenalidomide Revlimid R 62 Torisel 62 axillary dissection 62 FIRMAGON 62 recurrent metastatic 62 5-FU/LV 62 temsirolimus 62 taxane chemotherapy 62 low dose cytarabine 62 axitinib 62 aromatase inhibitor therapy 62 radioiodine therapy 62 ALND 62 immunosuppressive medication 62 sorafenib Nexavar 62 protease inhibitor PI 62 mitoxantrone 62 darunavir ritonavir 62 tumor recurrence 62 fulvestrant 62 pertuzumab 62 lapatinib Tykerb 62 adjuvant endocrine therapy 62 mg kg dose 62 vandetanib 62 sustained virologic response 62 chemotherapy regimens 62 hydroxychloroquine 62 breast cancer recurrence 62 partial remissions 62 dexamethasone Decadron 62 clodronate 62 cholinesterase inhibitor 62 radical nephrectomy 62 fondaparinux 62 antiretroviral regimen 62 docetaxel 62 cabazitaxel 62 trastuzumab Herceptin ® 62 adefovir 62 HER2 positive breast cancer 62 Lapatinib 62 virological response 62 Adjuvant chemotherapy 62 clinically localized prostate 62 gefitinib 62 imatinib 62 placebo dexamethasone 62 Bezielle 62 AGILECT R 62 premenopausal 62 Fludara 62 FASLODEX 62 HAART 62 dual antiplatelet therapy 62 eptifibatide 62 dosage regimens 61 antithrombotic therapy 61 heavily pretreated patients 61 dose dexamethasone 61 anti TNFs 61 dose cohort 61 elacytarabine 61 Femara letrozole 61 postmenopausal hormones 61 Kaplan Meier analysis 61 TNF inhibitor 61 PegIFN RBV 61 virologic response 61 HER2 negative 61 tumor resection 61 relapsing MS 61 operable breast cancer 61 bendamustine 61 infusional 5-FU/LV 61 unfractionated heparin 61 complete cytogenetic response 61 antiretroviral regimens 61 bevacizumab Avastin 61 #mg dose [001] 61 AVODART 61 RRMS patients 61 DMARD 61 chemotherapy cisplatin 61 nadolol 61 cangrelor 61 tumor shrinkage 61 teriparatide 61 biochemical recurrence 61 metastatic RCC 61 antiestrogen therapy 61 bicalutamide 61 oral rivaroxaban 61 cytogenetic response 61 estrogen progestin 61 dacarbazine 61 ribavirin therapy 61 progestogen 61 CCyR 61 Xelox 61 VIRAMUNE 61 antiviral therapy 61 Cladribine tablets 61 interferon alfa 2b 61 preoperative radiotherapy 61 epoetin beta 61 AROMASIN 61 NRTIs 61 clopidogrel Plavix 61 insulin detemir 61 durable remissions 61 infliximab 61 paroxysmal AF 61 dosing intervals 61 antihypertensive therapy 61 iniparib BSI 61 relapsed ovarian cancer 61 prostate cancer CRPC 61 dose titration 61 ritonavir boosted lopinavir 61 CIMZIA TM 61 dutasteride 61 ASCT 61 sorafenib 61 dosing cohort 61 neurologic progression 61 FOLFIRI 61 adriamycin 61 β blockers 61 external beam radiotherapy 61 breast cancer recurrences 61 dasatinib 61 bevacizumab 61 temozolomide 61 galiximab 61 gemcitabine chemotherapy 60 standard chemotherapy regimens 60 NATRECOR R 60 sustained virological response 60 lapatinib 60 divalproex sodium 60 anthracycline therapy 60 androgen deprivation therapy 60 biologic therapy 60 undergone hysterectomy 60 pegylated interferon alfa 60 Velcade bortezomib 60 MAGE A3 ASCI 60 locoregional recurrence 60 Gleevec imatinib 60 HSCT 60 efalizumab 60 pegylated interferon 60 anakinra 60 CR nPR 60 fluvastatin 60 sertraline 60 statin therapy 60 ribavirin RBV 60 5-fluorouracil/leucovorin 60 Dose escalation 60 octreotide 60 weekly subcutaneous injections 60 hydroxyurea 60 HER2 positive metastatic breast 60 Peg IFN 60 FOLFOX 60 progression TTP 60 immunomodulatory therapy 60 olaparib 60 EXJADE 60 tocilizumab 60 entecavir 60 Median survival 60 methotrexate monotherapy 60 fluorouracil 60 Sunitinib 60 tenofovir emtricitabine 60 chemotherapy docetaxel 60 FOLFIRINOX 60 antibiotic prophylaxis 60 Telintra 60 idraparinux 60 elotuzumab 60 endocrine therapy 60 thrombolytic therapy 60 idarubicin 60 COPAXONE R 60 endometrial hyperplasia 60 placebo controlled trials 60 COREG 60 DOXIL 60 abacavir lamivudine 60 plus progestin 60 capecitabine Xeloda 60 mCRC patients 60 thromboprophylaxis 60 DMARDs 60 YERVOY 60 INTELENCE 60 sentinel lymph node biopsy 60 exemestane Aromasin 60 tamsulosin 60 splenectomized patients 60 corticosteroid therapy 60 disease progression 60 cytotoxic chemotherapy 60 cisplatin 60 cytoreductive surgery 60 tamoxifen Nolvadex ® 60 Hydroxyurea 60 plus dexamethasone 60 LHRH agonists 60 pamidronate 60 Revlimid lenalidomide 60 Zevalin consolidation 60 heavily pretreated 60 hormone therapy estrogen 60 antiepileptic medications 60 cetuximab Erbitux 60 reinfarction 60 interferon ribavirin 60 SUTENT 60 complete cytogenetic 60 mRCC 60 pomalidomide 60 vasomotor symptoms 60 KAPIDEX 60 spontaneous preterm birth 60 paroxetine Paxil 60 erlotinib Tarceva 60 antiangiogenic therapy 60 estrogen progestin combination 60 remission CR 60 mesalamine granules 60 glargine 60 recurrent GBM 60 tolterodine 60 prednisone prednisolone 60 thromboembolic events 60 antiarrhythmic drugs 60 #mg ATC 60 peg interferon 60 mapatumumab 60 ixabepilone 60 LNG IUS 60 docetaxel Taxotere 60 VFEND 60 Folfox 60 irinotecan chemotherapy 60 odanacatib 60 ARB telmisartan 60 systemic ALCL 60 intraperitoneal therapy 60 azathioprine 60 dosing cohorts 60 rituximab 60 NATRECOR ® 60 adalimumab Humira 60 KRAS status 60 testosterone supplementation 60 KRAS mutations occur 60 tesmilifene 60 bolus dose 59 enzastaurin 59 hypogonadal men 59 LMWH 59 rosuvastatin 59 paclitaxel chemotherapy 59 cladribine tablets 59 prophylactic mastectomy 59 myeloablative 59 rindopepimut 59 gefitinib Iressa 59 pregabalin 59 Zolinza 59 gemcitabine 59 ovarian stimulation 59 TYKERB 59 rapid virologic response 59 metastatic kidney 59 trabectedin 59 FROVA 59 leflunomide 59 Taxotere 59 daclizumab 59 CRp 59 Neoadjuvant 59 APTIVUS 59 randomized controlled clinical trials 59 oblimersen 59 reperfusion therapy 59 dose regimens 59 celecoxib 59 teriflunomide 59 liver biopsies 59 trastuzumab DM1 59 TDF FTC 59 autologous transplants 59 contralateral breast cancer 59 peg IFN 59 rFSH 59 pegylated interferon alpha 59 pneumonectomy 59 aldosterone antagonists 59 Anastrozole 59 invasive candidiasis 59 elagolix 59 tumor histology 59 colorectal liver metastases 59 gemcitabine carboplatin 59 MabCampath 59 uric acid lowering 59 venous thromboembolic events 59 PREZISTA r 59 Ophena 59 single dose nevirapine 59 thalidomide Thalomid 59 octreotide LAR 59 ibandronate 59 surgical debulking 59 levetiracetam 59 epirubicin 59 gout flares 59 thalidomide dexamethasone 59 TACE 59 cediranib 59 underwent liver transplantation 59 anti TNF 59 complete remissions 59 hormone receptor positive 59 bisphosphonate 59 pelvic lymphadenectomy 59 Elitek 59 ticlopidine 59 orchiectomy 59 locoregional 59 menstrual migraine 59 R0 resection 59 undetectable HCV RNA 59 oral contraception 59 TNF inhibitors 59 APTIVUS R 59 5FU 59 conjugated equine estrogens 59 liver metastases 59 amoxicillin clavulanate 59 bortezomib 59 LEXIVA r 59 COPAXONE ® 59 Flu Cy 59 VELCADE melphalan 59 peritoneal cancer 59 docetaxel Taxotere ® 59 sentinel node biopsy 59 abnormal mammograms 59 GnRH antagonist 59 CHOP chemotherapy 59 placebo controlled clinical 59 angiographic restenosis 59 steroid dexamethasone 59 Ophena TM 59 conjugated equine estrogen 59 SCIg 59 Amrubicin 59 VIRAMUNE XR 59 etanercept 59 REYATAZ 59 neoadjuvant radiation 59 insulin glargine 59 chemoradiation therapy 59 genotypic resistance 59 TroVax ® 59 capecitabine 59 ritonavir boosted protease inhibitor 59 MGd 59 adenoma recurrence 59 Pemetrexed 59 ritonavir boosted 59 NNRTI resistance 59 interferon alfa 59 relapsed AML 59 undetectable viral load 59 alendronate 59 bronchial thermoplasty 59 docetaxel prednisone 59 gemcitabine Gemzar 59 #mg dose [003] 59 REVLIMID ® 59 colectomy 59 bezafibrate 59 Pegasys plus Copegus 59 PEG IFN 59 IFN beta 59 brain metastases 59 raltegravir 59 metastatic renal cell carcinoma 59 BRCA mutation 59 Lamictal XR 59 tiotropium 59 calcineurin inhibitor 59 PegIntron 59 ancrod 58 elective PCI 58 SLN biopsy 58 antiplatelet medication 58 stage IIIB IV 58 hormone deprivation 58 systemic corticosteroids 58 carvedilol 58 romiplostim 58 concurrent chemoradiation 58 distant metastases 58 cetuximab 58 pyrazinamide 58 #mg dose [002] 58 clopidogrel 58 YONDELIS 58 subcutaneous enoxaparin 58 revascularization procedures 58 IV NSCLC 58 metastatic castration resistant 58 Q#IR 58 adjuvant therapies 58 mg QD 58 canakinumab 58 zidovudine lamivudine 58 Faslodex 58 coronary revascularization 58 resectable 58 SSRI antidepressant 58 afatinib 58 advanced adenomas 58 refractory CLL 58 epirubicin cyclophosphamide 58 Traficet EN 58 CIMZIA ™ 58 Irinotecan 58 therapeutic regimens 58 postmenopausal osteoporotic women 58 clomipramine 58 phase IIb trial 58 adenomatous polyps 58 rtPA 58 gadobutrol 58 evaluable subjects 58 vicriviroc 58 Allovectin 7 ® 58 oral clodronate 58 FOLPI 58 advanced HER2 positive 58 Trastuzumab 58 postoperative radiotherapy 58 oral contraceptive pills 58 antimicrobial prophylaxis 58 atazanavir 58 rFVIIa 58 nab paclitaxel 58 pegylated interferon alfa 2b 58 oral contraceptive pill 58 Xeloda 58 forodesine 58 HCV infected 58 PSADT 58 advanced adenoma 58 Teriflunomide 58 epithelial ovarian cancer 58 strontium ranelate 58 tipranavir ritonavir 58 carotid endarterectomy CEA 58 tipranavir 58 SPRYCEL 58 recurrent ovarian cancer 58 cranial irradiation 58 3TC lamivudine Epivir 58 postoperative mortality 58 HGS# 58 methotrexate 58 endocrine responsive 58 ATACAND 58 enfuvirtide 58 anastrazole 58 Raptiva r 58 nelfinavir 58 Free Survival PFS 58 sevelamer 58 aspirin therapy 58 irbesartan 58 NNRTI 58 Topotecan 58 EDSS scores 58 lenalidomide 58 HER2 positive tumors 58 Dasatinib 58 paclitaxel Taxol 58 Tarceva TM 58 ICD implantation 58 intensive statin therapy 58 alefacept 58 serum calcium levels 58 estrogen hormone therapy 58 interferon beta therapy 58 ABVD 58 biologic DMARD 58 liver resection 58 apremilast 58 CANCIDAS 58 TBC# 58 Capecitabine 58 Cisplatin 58 daunorubicin 58 pemetrexed 58 lamotrigine 58 achieved ACR# 58 paclitaxel eluting stents 58 FTY# 58 CYPHER Stent 58 oxaliplatin Eloxatin 58 fallopian tube carcinoma 58 immunosuppressive agents 58 lymphadenectomy 58 BEXXAR therapeutic regimen 58 Proellex TM 58 Heplisav 58 visilizumab 58 venlafaxine ER 58 ONTAK 58 oral ridaforolimus 58 ARCOXIA 58 median PFS 58 metastatic lung cancer 58 ritonavir boosted atazanavir 58 antiepileptic drugs 58 fluconazole 58 pramipexole 58 nonfatal MI 58 Erlotinib 58 certolizumab 58 eplerenone 58 dose cohorts 58 MIRCERA 58 IELT 58 bilateral oophorectomy 58 dacarbazine chemotherapy 58 infliximab Remicade 58 levosimendan 58 hsCRP levels 58 concomitant medications 58 Gemcitabine 58 MAS XR 58 MS relapses 58 APTIVUS ritonavir 58 antihypertensive drugs 58 vinorelbine 58 chemopreventive agent 58 recurrent miscarriage 58 non squamous NSCLC 58 spontaneous preterm delivery 58 vertebral fracture 58 ziprasidone 58 seroconversion 58 ABSORB trial 58 figitumumab 58 pegfilgrastim 58 Cytoxan 58 mcg dose 58 chemo radiotherapy 58 sulphonylureas 58 Reverset 58 citalopram Celexa 58 NNRTIs 58 timepoint 58 BRAF mutation 58 levodopa therapy 58 hepatectomy 58 platelet reactivity 58 valproate 58 HBeAg positive patients 58 ALT flares 58 imipenem 58 hormonal treatments 58 BoNTA 58 AMEVIVE 58 anticoagulant therapy 58 virologic suppression 58 paricalcitol 58 perioperatively 58 Taxotere ® 58 Tarceva erlotinib 57 d4T 57 monotherapy 57 folinic acid 57 riociguat 57 MIRAPEX 57 muraglitazar 57 weekly intravenous infusions 57 relapsed SCLC 57 pancreatic adenocarcinoma 57 ELOXATIN 57 nortriptyline 57 nitazoxanide 57 pyridostigmine 57 baseline HbA1c 57 HNSCC 57 patients evaluable 57 efavirenz EFV 57 intraperitoneal chemotherapy 57 tamoxifen Nolvadex 57 anti androgen 57 TTF Therapy 57 phase IIb clinical 57 HBeAg seroconversion 57 intramuscular injections 57 progestagen 57 bevacizumab Avastin ® 57 sirolimus 57 plasma uric acid 57 co trimoxazole 57 rivaroxaban 57 pegylated interferon alfa 2a 57 metastatic GIST 57 H. pylori eradication 57 PROMACTA 57 curative therapy 57 folate supplementation 57 lipid lowering medication 57 cervical intraepithelial neoplasia 57 oncologic outcomes 57 citalopram 57 EFAPROXYN 57 atherothrombotic events 57 BENICAR HCT 57 peginterferon alfa 2b 57 Gliadel Wafer 57 Halaven 57 fludarabine 57 hematologic toxicity 57 inhaled steroids 57 NRTI 57 mg RDEA# 57 stable angina 57 vaginal hysterectomy 57 Panzem R NCD 57 FOLFOX6 57 undergoing hysterectomy 57 SERMs 57 peginterferon alfa 2a 57 intravenous chemotherapy 57 tacrolimus ointment 57 TNF antagonist 57 PSA nadir 57 lenalidomide dexamethasone 57 CsA 57 preventive mastectomy 57 ximelagatran 57 EGFRIs 57 oral anticoagulation 57 oral deforolimus 57 Cetuximab 57 poor metabolizers 57 trials RCTs 57 Xyotax 57 DES implantation 57 alkylating agent 57 posaconazole 57 paclitaxel carboplatin 57 anticlotting drugs 57 STRIDE PD 57 antibiotic therapy 57 overlapping toxicities 57 lomitapide 57 cardiac toxicity 57 oral prednisone 57 Platinol ® cisplatin 57 zidovudine 57 Hormonal therapy 57 prostate adenocarcinoma 57 montelukast 57 Tocosol Paclitaxel 57 venlafaxine 57 ustekinumab 57 BEXXAR 57 tremelimumab 57 PEGINTRON TM 57 amrubicin 57 CYP#D# inhibitor 57 drug eluting stent implantation 57 ELACYT 57 androgen therapy 57 estramustine 57 metastatic CRC 57 Vectibix monotherapy 57 thrombolytic agents 57 cervical lesions 57 IRESSA 57 Natalizumab 57 aromatase inhibitors AIs 57 postintervention 57 anti angiogenic therapy 57 DEB# 57 TEMODAL 57 dalteparin 57 detectable HCV RNA 57 doxorubicin docetaxel 57 ER CHOP 57 FAMPYRA 57 viral suppression 57 VIDAZA 57 recurrent glioblastoma multiforme 57 Advagraf 57 HPV-#/# 57 antihypertensive medications 57 free survival PFS 57 oral FTY# 57 surrogate endpoint 57 chemoembolization 57 Hepatocellular Carcinoma HCC 57 Riluzole 57 panitumumab 57 Acute Coronary Syndromes ACS 57 intra arterial chemotherapy 57 antiretroviral therapy 57 #mg/day [002] 57 degarelix 57 GP IIb IIIa inhibitors 57 ofpatients 57 Combination therapy 57 BRCA testing 57 adenotonsillectomy 57 undetectable HBV DNA 57 Degarelix 57 virologic 57 abdominal hysterectomy 57 QTc prolongation 57 immunosuppressive therapies 57 milligram doses 57 ACTEMRA TM 57 corticosteroids 57 BEACOPP 57 5 Fluorouracil 57 darunavir 57 nifedipine 57 tinzaparin 57 oral corticosteroids 57 sipuleucel T 57 Hycamtin 57 ISENTRESS 57 disease modifying antirheumatic 57 ethambutol 57 lobular cancer 57 Cimzia R 57 stage IIIB 57 neostigmine 57 Mitoxantrone 57 invasive breast cancer 57 micafungin 57 Radical prostatectomy 57 immunosuppressant therapy 57 urate lowering therapy 57 metastatic hormone refractory 57 Bortezomib 57 RSD# oral 57 TKI therapy 57 Zytiga 57 PASI scores 57 undergone radical prostatectomy 57 aldosterone antagonist 57 Taxotere chemotherapy 57 precancerous cervical lesions 57 erlotinib 57 OHR/AVR# 57 venous thromboembolism 57 corrected QT interval 57 L dopa 57 imatinib Gleevec 57 enoxaparin 57 nonmetastatic prostate cancer 57 administered subcutaneously 57 NRTI backbone 57 antiplatelet agent 57 squamous histology 57 radical prostatectomy 57 antiretroviral naive 57 valproic acid 57 antithymocyte globulin 57 vaginal progesterone 57 hepatic resection 57 Gefitinib 57 recurrent prostate cancer 57 LHRH analogues 57 contralateral breast 57 erlotinib Tarceva ® 57 induce remission 57 QTc 57 tecarfarin 57 ipsilateral stroke 57 adjuvant trastuzumab 57 tumor regression 57 paclitaxel Taxol R 57 medically inoperable 57 doxazosin 57 remission induction 57 cilengitide 57 RLAI 57 anthracycline containing 57 paclitaxel cisplatin 57 statin medications 57 DCVax R Brain 57 salpingo oophorectomy 57 BRCA mutations 57 pioglitazone 57 omalizumab 57 randomized trials 57 postmenopausal 57 OncoVEX GM CSF 57 recurrent venous thromboembolism 57 deferiprone 57 ALGRX 57 statin 57 NMIBC 57 thrombocytopenic 57 cisplatin vinorelbine 57 epoetin alfa 57 INCB# [001] 57 care regimens CCR 57 NAbs 57 stent implantation 57 pazopanib 57 stage IIIb IV 57 Novartis Zometa 57 relapsing remitting MS RRMS 57 Adjuvant therapy 57 bowel resection 57 Arimidex anastrozole 57 KRAS mutations 57 Navelbine ® 57 nonmetastatic 57 Fludara ® 57 hepatic metastases 57 receptor tyrosine kinase inhibitor 57 menopausal symptoms 57 definite stent thrombosis 57 COPEGUS 57 #mg doses [002] 57 candesartan 57 everolimus eluting stents 57 androgen blockade 57 mycophenolate mofetil MMF 57 secondary amenorrhea 57 bazedoxifene 57 SLNB 57 daily subcutaneous injections 57 dietary questionnaires 57 nulliparous women 57 stavudine d4T 57 glatiramer acetate 57 systemic corticosteroid 57 FSAD 57 EGFR TKI 57 oral anticoagulant 57 nonvertebral fractures 57 Vagifem 57 biliary tract cancer 56 Raptiva ® 56 histologically confirmed 56 mcg kg 56 thoracoscopic lobectomy 56 Betaferon ® 56 Aflibercept 56 radiochemotherapy 56 corifollitropin alfa 56 rt PA 56 platelet inhibitor 56 zidovudine AZT 56 bupropion SR 56 Uricase PEG 56 boosted protease inhibitor 56 BRCA2 mutation carriers 56 postmenopausal women